Ourmazd Ojan

Array ( [id] => 4043656 [patent_doc_number] => 05912133 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-15 [patent_title] => 'Method for isolating stem cells expressing flk-1 receptors' [patent_app_type] => 1 [patent_app_number] => 9/021324 [patent_app_country] => US [patent_app_date] => 1998-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 26946 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/912/05912133.pdf [firstpage_image] =>[orig_patent_app_number] => 021324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3941680 [patent_doc_number] => 05976810 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Method of detecting autoantibody present in the serum of rheumatic' [patent_app_type] => 1 [patent_app_number] => 8/793937 [patent_app_country] => US [patent_app_date] => 1997-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 6622 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/976/05976810.pdf [firstpage_image] =>[orig_patent_app_number] => 793937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3863995 [patent_doc_number] => 05762927 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Thymus tolerance in primates' [patent_app_type] => 1 [patent_app_number] => 8/827772 [patent_app_country] => US [patent_app_date] => 1997-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2146 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/762/05762927.pdf [firstpage_image] =>[orig_patent_app_number] => 827772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3758087 [patent_doc_number] => 05843716 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Polynucleotide encoding a proline-rich membrane protein' [patent_app_type] => 1 [patent_app_number] => 8/794216 [patent_app_country] => US [patent_app_date] => 1997-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 18841 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843716.pdf [firstpage_image] =>[orig_patent_app_number] => 794216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3876004 [patent_doc_number] => 05824776 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Cell-targeted lytic pore-forming agents' [patent_app_type] => 1 [patent_app_number] => 8/759442 [patent_app_country] => US [patent_app_date] => 1996-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 8051 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824776.pdf [firstpage_image] =>[orig_patent_app_number] => 759442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3931454 [patent_doc_number] => 05928893 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Monoclonal antibody specific for human 4-1BB and cell line producing same' [patent_app_type] => 1 [patent_app_number] => 8/737560 [patent_app_country] => US [patent_app_date] => 1996-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8707 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/928/05928893.pdf [firstpage_image] =>[orig_patent_app_number] => 737560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4010860 [patent_doc_number] => 05879899 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-09 [patent_title] => 'Methods of assaying DNA-repairing enzymes and their alkylated derivatives' [patent_app_type] => 1 [patent_app_number] => 8/676122 [patent_app_country] => US [patent_app_date] => 1996-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 8081 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/879/05879899.pdf [firstpage_image] =>[orig_patent_app_number] => 676122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3879980 [patent_doc_number] => 05728814 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-17 [patent_title] => 'GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies' [patent_app_type] => 1 [patent_app_number] => 8/707801 [patent_app_country] => US [patent_app_date] => 1996-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11638 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/728/05728814.pdf [firstpage_image] =>[orig_patent_app_number] => 707801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3784257 [patent_doc_number] => 05840504 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Method for separating sex specific molecules and non-sex specific molecules' [patent_app_type] => 1 [patent_app_number] => 8/694784 [patent_app_country] => US [patent_app_date] => 1996-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12808 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840504.pdf [firstpage_image] =>[orig_patent_app_number] => 694784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3985831 [patent_doc_number] => 05891439 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Lymphocyte stimulating factor' [patent_app_type] => 1 [patent_app_number] => 8/686599 [patent_app_country] => US [patent_app_date] => 1996-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 7361 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891439.pdf [firstpage_image] =>[orig_patent_app_number] => 686599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3756770 [patent_doc_number] => 05741489 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-21 [patent_title] => 'Passively administered antibody that enhances feed conversion efficiency' [patent_app_type] => 1 [patent_app_number] => 8/653604 [patent_app_country] => US [patent_app_date] => 1996-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3627 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/741/05741489.pdf [firstpage_image] =>[orig_patent_app_number] => 653604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3756683 [patent_doc_number] => 05843633 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Characterization of a human hematopoietic progenitor cell antigen' [patent_app_type] => 1 [patent_app_number] => 8/639891 [patent_app_country] => US [patent_app_date] => 1996-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 16 [patent_no_of_words] => 8250 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843633.pdf [firstpage_image] =>[orig_patent_app_number] => 639891 [rel_patent_id] =>[rel_patent_doc_number] =>)